title: Novel biopanning strategy to identify epitopes associated with vaccine protection.
abstract: Identifying immune correlates of protection is important to develop vaccines against infectious diseases. We designed a novel, universally applicable strategy to profile the antibody (Ab) repertoire of protected vaccine recipients, using recombinant phages encoding random peptide libraries. The new approach, termed "protection-linked (PL) biopanning," probes the Ab paratopes of protected vaccinees versus those with vaccine failure. As proof of concept, we screened plasma samples from vaccinated rhesus macaques (RMs) that had completely resisted multiple mucosal challenges with R5-tropic simian-human immunodeficiency viruses (SHIVs). The animals had been immunized with a multicomponent vaccine (multimeric HIV-1 gp160, HIV-1 Tat, and SIV Gag-Pol particles). After PL biopanning, we analyzed the phagotopes selected for amino acid homologies; in addition to the expected Env mimotopes, one recurring motif reflected the neutralizing Ab epitope at the N terminus (NT) of HIV-1 Tat. Subsequent binding and functional assays indicated that anti-Tat NT Abs were present only in completely or partially protected RMs; peak viremia of the latter was inversely correlated with anti-Tat NT Ab titers. In contrast, highly viremic, unvaccinated controls did not develop detectable Abs against the same epitope. Based upon the protective effect observed in vivo, we suggest that Tat should be included in multicomponent HIV-1 vaccines. Our data highlight the power of the new PL-biopanning strategy to identify Ab responses with significant association to vaccine protection, regardless of the mechanism(s) or targets of the protective Abs. PL biopanning is also unbiased with regard to pathogens or disease model, making it a universal tool.
authors: Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
authors: Barbara C
authors: BC
authors: Bachler
authors: Michael
authors: M
authors: Humbert
authors: Brisa
authors: B
authors: Palikuqi
authors: Nagadenahalli B
authors: NB
authors: Siddappa
authors: Samir K
authors: SK
authors: Lakhashe
authors: Robert A
authors: RA
authors: Rasmussen
authors: Ruth M
authors: RM
authors: Ruprecht
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D000818:Animals; D000906:Antibodies / Q000097:blood*; D057134:Antibodies, Neutralizing / Q000097:blood; D000956:Antigens, Viral / Q000276:immunology*; D000939:Epitopes / Q000276:immunology*; D015696:Gene Products, tat / Q000276:immunology; D015497:HIV-1 / Q000276:immunology; D007158:Immunologic Techniques / Q000379:methods; D008253:Macaca mulatta; D019151:Peptide Library; D018449:SAIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D015302:Simian Immunodeficiency Virus / Q000276:immunology
chemical_list: D016915:AIDS Vaccines; D000906:Antibodies; D057134:Antibodies, Neutralizing; D000956:Antigens, Viral; D000939:Epitopes; D015696:Gene Products, tat; D019151:Peptide Library; D018449:SAIDS Vaccines
references: Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13153-8
references: 9789057
references: J Immunol Methods. 1996 Oct 16;197(1-2):193-6
references: 8890907
references: J Comput Chem. 2004 Oct;25(13):1605-12
references: 15264254
references: Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7941-5
references: 7690138
references: J Med Primatol. 2011 Apr;40(2):120-8
references: 21044092
references: Curr Opin Virol. 2011 Oct;1(4):246-53
references: 22081778
references: Nature. 1986 Mar 27-Apr 2;320(6060):367-71
references: 3007995
references: AIDS Res Hum Retroviruses. 2000 Sep 1;16(13):1247-57
references: 10957722
references: PLoS One. 2012;7(6):e38943
references: 22737224
references: DNA Cell Biol. 2002 Sep;21(9):637-51
references: 12396606
references: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8324-6
references: 10411869
references: J Virol. 1993 Jan;67(1):277-87
references: 8416373
references: Nat Immunol. 2012 Apr 18;13(5):423-7
references: 22513323
references: AIDS. 2007 Sep 12;21(14):1841-8
references: 17721091
references: Vaccine. 2011 Aug 5;29(34):5611-22
references: 21693155
references: C R Acad Sci III. 2000 Oct;323(10):883-94
references: 11098404
references: Eur J Immunol. 2007 Feb;37(2):501-15
references: 17236253
references: Vaccine. 2001 Feb 8;19(13-14):1738-46
references: 11166899
references: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3515-9
references: 10725402
references: J Gen Virol. 1997 Aug;78 ( Pt 8):1913-8
references: 9266987
references: PLoS One. 2011 Mar 31;6(3):e18207
references: 21483815
references: Nat Rev Immunol. 2010 Jan;10(1):11-23
references: 20010788
references: N Engl J Med. 2012 Apr 5;366(14):1275-86
references: 22475592
references: New Biol. 1990 May;2(5):479-86
references: 1981148
references: Retrovirology. 2009 May 25;6:50
references: 19467159
references: Vaccine. 2009 Nov 12;27(48):6739-47
references: 19744585
references: J Virol Methods. 2010 Oct;169(1):95-102
references: 20637241
references: Cell Res. 2005 Nov-Dec;15(11-12):923-34
references: 16354571
references: FASEB J. 2001 Oct;15(12):2112-20
references: 11641237
references: N Engl J Med. 2009 Dec 3;361(23):2209-20
references: 19843557
references: J Virol. 2003 Mar;77(5):3157-66
references: 12584340
references: Retrovirology. 2006 Jan 27;3:8
references: 16441880
references: Genome Res. 2004 Jun;14(6):1188-90
references: 15173120
references: Annu Rev Med. 2012;63:113-30
references: 22077718
references: AIDS. 1997 Oct;11(12):1421-31
references: 9342064
references: Cell. 1990 Aug 24;62(4):757-67
references: 2201451
references: PLoS One. 2012;7(8):e41469
references: 22870226
references: J Hum Virol. 1998 May-Jun;1(4):282-92
references: 10195253
references: Curr Opin HIV AIDS. 2011 Sep;6(5):427-34
references: 21734565
references: Haematol Blood Transfus. 1987;31:395-403
references: 2895046
references: J Gene Med. 2009 Nov;11(11):955-65
references: 19653251
references: AIDS. 2012 Jan 14;26(2):149-55
references: 21941166
references: PLoS One. 2012;7(11):e48781
references: 23152803
references: J Immunol. 1999 May 15;162(10):6155-61
references: 10229859
references: J Virol. 2009 May;83(9):4102-11
references: 19224993
references: PLoS One. 2011;6(7):e22010
references: 21799765
references: Nucleic Acids Res. 1990 Oct 25;18(20):6097-100
references: 2172928
references: PLoS One. 2010 Jan 20;5(1):e8805
references: 20098712
references: J Virol. 2004 Dec;78(23):13190-6
references: 15542671
references: J Virol. 2002 Apr;76(8):3800-9
references: 11907220
references: Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11181-6
references: 21690411
references: J Virol. 2004 Apr;78(7):3792-6
references: 15016898
references: PLoS One. 2008;3(12):e3937
references: 19081789
references: Trends Genet. 2010 Mar;26(3):119-31
references: 20149939
references: Nat Med. 1999 Jun;5(6):643-50
references: 10371502
references: J Clin Virol. 2001 Apr;21(1):81-9
references: 11255101
references: J Infect Dis. 2005 Apr 15;191(8):1321-4
references: 15776379
references: FASEB J. 1991 Jul;5(10):2361-8
references: 1712325
references: J Virol. 2010 Jul;84(14):7161-73
references: 20444898
references: Int Rev Immunol. 2009;28(5):285-334
references: 19811313
references: Immunity. 2010 Oct 29;33(4):542-54
references: 21029964
references: Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007310
references: 22675663
references: Blood. 2005 Apr 1;105(7):2802-11
references: 15591114
references: J Virol. 2006 Sep;80(17):8729-38
references: 16912320
references: J Med Virol. 1988 Nov;26(3):261-70
references: 2462614
references: Vaccine. 2004 Sep 3;22(25-26):3258-69
references: 15308348
references: J Biol Chem. 1999 Oct 8;274(41):28837-40
references: 10506122
references: J Gen Virol. 2004 Oct;85(Pt 10):2893-2901
references: 15448351
references: Vaccine. 2010 May 26;28 Suppl 2:B25-31
references: 20510739